0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flurbiprofen Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18W5863
Home | Market Reports | Health| Nursing
Global Flurbiprofen Market Insights and Forecast to 2028
BUY CHAPTERS

Global Flurbiprofen Market Research Report 2025

Code: QYRE-Auto-18W5863
Report
September 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Flurbiprofen Market

The global market for Flurbiprofen was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Flurbiprofen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Flurbiprofen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Flurbiprofen in Nonsteroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Flurbiprofen include Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie, Abbott, Allergan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flurbiprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flurbiprofen.
The Flurbiprofen market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flurbiprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flurbiprofen companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Flurbiprofen Market Report

Report Metric Details
Report Name Flurbiprofen Market
Segment by Type
  • Injection
  • Patch
  • Tablet
Segment by Application
  • Nonsteroidal Anti-Inflammatory Drugs
  • Topical Administration for Joint And Muscle Pain
  • Soft Tissue Disease
  • Dysmenorrhea
  • Post-Operative Pain
  • Toothache
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie, Abbott, Allergan, Pharma-Logic, Kaken Pharma, Mitsubishi Tanab, Sun Pharma, Aa Pharma, Pro Doc Limitee, PD-Rx Pharmaceuticals, Beijing Taide Pharmaceutical, Wuhan Daan Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Flurbiprofen company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Flurbiprofen Market report?

Ans: The main players in the Flurbiprofen Market are Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie, Abbott, Allergan, Pharma-Logic, Kaken Pharma, Mitsubishi Tanab, Sun Pharma, Aa Pharma, Pro Doc Limitee, PD-Rx Pharmaceuticals, Beijing Taide Pharmaceutical, Wuhan Daan Pharmaceutical

What are the Application segmentation covered in the Flurbiprofen Market report?

Ans: The Applications covered in the Flurbiprofen Market report are Nonsteroidal Anti-Inflammatory Drugs, Topical Administration for Joint And Muscle Pain, Soft Tissue Disease, Dysmenorrhea, Post-Operative Pain, Toothache, Other

What are the Type segmentation covered in the Flurbiprofen Market report?

Ans: The Types covered in the Flurbiprofen Market report are Injection, Patch, Tablet

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flurbiprofen Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Patch
1.2.4 Tablet
1.3 Market by Application
1.3.1 Global Flurbiprofen Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Nonsteroidal Anti-Inflammatory Drugs
1.3.3 Topical Administration for Joint And Muscle Pain
1.3.4 Soft Tissue Disease
1.3.5 Dysmenorrhea
1.3.6 Post-Operative Pain
1.3.7 Toothache
1.3.8 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flurbiprofen Market Perspective (2020-2031)
2.2 Global Flurbiprofen Growth Trends by Region
2.2.1 Global Flurbiprofen Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Flurbiprofen Historic Market Size by Region (2020-2025)
2.2.3 Flurbiprofen Forecasted Market Size by Region (2026-2031)
2.3 Flurbiprofen Market Dynamics
2.3.1 Flurbiprofen Industry Trends
2.3.2 Flurbiprofen Market Drivers
2.3.3 Flurbiprofen Market Challenges
2.3.4 Flurbiprofen Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flurbiprofen Players by Revenue
3.1.1 Global Top Flurbiprofen Players by Revenue (2020-2025)
3.1.2 Global Flurbiprofen Revenue Market Share by Players (2020-2025)
3.2 Global Flurbiprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Flurbiprofen Revenue
3.4 Global Flurbiprofen Market Concentration Ratio
3.4.1 Global Flurbiprofen Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flurbiprofen Revenue in 2024
3.5 Global Key Players of Flurbiprofen Head office and Area Served
3.6 Global Key Players of Flurbiprofen, Product and Application
3.7 Global Key Players of Flurbiprofen, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Flurbiprofen Breakdown Data by Type
4.1 Global Flurbiprofen Historic Market Size by Type (2020-2025)
4.2 Global Flurbiprofen Forecasted Market Size by Type (2026-2031)
5 Flurbiprofen Breakdown Data by Application
5.1 Global Flurbiprofen Historic Market Size by Application (2020-2025)
5.2 Global Flurbiprofen Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Flurbiprofen Market Size (2020-2031)
6.2 North America Flurbiprofen Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Flurbiprofen Market Size by Country (2020-2025)
6.4 North America Flurbiprofen Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flurbiprofen Market Size (2020-2031)
7.2 Europe Flurbiprofen Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Flurbiprofen Market Size by Country (2020-2025)
7.4 Europe Flurbiprofen Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flurbiprofen Market Size (2020-2031)
8.2 Asia-Pacific Flurbiprofen Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Flurbiprofen Market Size by Region (2020-2025)
8.4 Asia-Pacific Flurbiprofen Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flurbiprofen Market Size (2020-2031)
9.2 Latin America Flurbiprofen Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Flurbiprofen Market Size by Country (2020-2025)
9.4 Latin America Flurbiprofen Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flurbiprofen Market Size (2020-2031)
10.2 Middle East & Africa Flurbiprofen Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Flurbiprofen Market Size by Country (2020-2025)
10.4 Middle East & Africa Flurbiprofen Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Flurbiprofen Introduction
11.1.4 Teva Revenue in Flurbiprofen Business (2020-2025)
11.1.5 Teva Recent Development
11.2 Mylan Pharmaceuticals
11.2.1 Mylan Pharmaceuticals Company Details
11.2.2 Mylan Pharmaceuticals Business Overview
11.2.3 Mylan Pharmaceuticals Flurbiprofen Introduction
11.2.4 Mylan Pharmaceuticals Revenue in Flurbiprofen Business (2020-2025)
11.2.5 Mylan Pharmaceuticals Recent Development
11.3 Tokuhon
11.3.1 Tokuhon Company Details
11.3.2 Tokuhon Business Overview
11.3.3 Tokuhon Flurbiprofen Introduction
11.3.4 Tokuhon Revenue in Flurbiprofen Business (2020-2025)
11.3.5 Tokuhon Recent Development
11.4 Recordati
11.4.1 Recordati Company Details
11.4.2 Recordati Business Overview
11.4.3 Recordati Flurbiprofen Introduction
11.4.4 Recordati Revenue in Flurbiprofen Business (2020-2025)
11.4.5 Recordati Recent Development
11.5 Mikasa Seiyaku
11.5.1 Mikasa Seiyaku Company Details
11.5.2 Mikasa Seiyaku Business Overview
11.5.3 Mikasa Seiyaku Flurbiprofen Introduction
11.5.4 Mikasa Seiyaku Revenue in Flurbiprofen Business (2020-2025)
11.5.5 Mikasa Seiyaku Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Flurbiprofen Introduction
11.6.4 Bausch Health Revenue in Flurbiprofen Business (2020-2025)
11.6.5 Bausch Health Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Flurbiprofen Introduction
11.7.4 Pfizer Revenue in Flurbiprofen Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Flurbiprofen Introduction
11.8.4 AbbVie Revenue in Flurbiprofen Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Flurbiprofen Introduction
11.9.4 Abbott Revenue in Flurbiprofen Business (2020-2025)
11.9.5 Abbott Recent Development
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Flurbiprofen Introduction
11.10.4 Allergan Revenue in Flurbiprofen Business (2020-2025)
11.10.5 Allergan Recent Development
11.11 Pharma-Logic
11.11.1 Pharma-Logic Company Details
11.11.2 Pharma-Logic Business Overview
11.11.3 Pharma-Logic Flurbiprofen Introduction
11.11.4 Pharma-Logic Revenue in Flurbiprofen Business (2020-2025)
11.11.5 Pharma-Logic Recent Development
11.12 Kaken Pharma
11.12.1 Kaken Pharma Company Details
11.12.2 Kaken Pharma Business Overview
11.12.3 Kaken Pharma Flurbiprofen Introduction
11.12.4 Kaken Pharma Revenue in Flurbiprofen Business (2020-2025)
11.12.5 Kaken Pharma Recent Development
11.13 Mitsubishi Tanab
11.13.1 Mitsubishi Tanab Company Details
11.13.2 Mitsubishi Tanab Business Overview
11.13.3 Mitsubishi Tanab Flurbiprofen Introduction
11.13.4 Mitsubishi Tanab Revenue in Flurbiprofen Business (2020-2025)
11.13.5 Mitsubishi Tanab Recent Development
11.14 Sun Pharma
11.14.1 Sun Pharma Company Details
11.14.2 Sun Pharma Business Overview
11.14.3 Sun Pharma Flurbiprofen Introduction
11.14.4 Sun Pharma Revenue in Flurbiprofen Business (2020-2025)
11.14.5 Sun Pharma Recent Development
11.15 Aa Pharma
11.15.1 Aa Pharma Company Details
11.15.2 Aa Pharma Business Overview
11.15.3 Aa Pharma Flurbiprofen Introduction
11.15.4 Aa Pharma Revenue in Flurbiprofen Business (2020-2025)
11.15.5 Aa Pharma Recent Development
11.16 Pro Doc Limitee
11.16.1 Pro Doc Limitee Company Details
11.16.2 Pro Doc Limitee Business Overview
11.16.3 Pro Doc Limitee Flurbiprofen Introduction
11.16.4 Pro Doc Limitee Revenue in Flurbiprofen Business (2020-2025)
11.16.5 Pro Doc Limitee Recent Development
11.17 PD-Rx Pharmaceuticals
11.17.1 PD-Rx Pharmaceuticals Company Details
11.17.2 PD-Rx Pharmaceuticals Business Overview
11.17.3 PD-Rx Pharmaceuticals Flurbiprofen Introduction
11.17.4 PD-Rx Pharmaceuticals Revenue in Flurbiprofen Business (2020-2025)
11.17.5 PD-Rx Pharmaceuticals Recent Development
11.18 Beijing Taide Pharmaceutical
11.18.1 Beijing Taide Pharmaceutical Company Details
11.18.2 Beijing Taide Pharmaceutical Business Overview
11.18.3 Beijing Taide Pharmaceutical Flurbiprofen Introduction
11.18.4 Beijing Taide Pharmaceutical Revenue in Flurbiprofen Business (2020-2025)
11.18.5 Beijing Taide Pharmaceutical Recent Development
11.19 Wuhan Daan Pharmaceutical
11.19.1 Wuhan Daan Pharmaceutical Company Details
11.19.2 Wuhan Daan Pharmaceutical Business Overview
11.19.3 Wuhan Daan Pharmaceutical Flurbiprofen Introduction
11.19.4 Wuhan Daan Pharmaceutical Revenue in Flurbiprofen Business (2020-2025)
11.19.5 Wuhan Daan Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Flurbiprofen Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Injection
 Table 3. Key Players of Patch
 Table 4. Key Players of Tablet
 Table 5. Global Flurbiprofen Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Flurbiprofen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Flurbiprofen Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Flurbiprofen Market Share by Region (2020-2025)
 Table 9. Global Flurbiprofen Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Flurbiprofen Market Share by Region (2026-2031)
 Table 11. Flurbiprofen Market Trends
 Table 12. Flurbiprofen Market Drivers
 Table 13. Flurbiprofen Market Challenges
 Table 14. Flurbiprofen Market Restraints
 Table 15. Global Flurbiprofen Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Flurbiprofen Market Share by Players (2020-2025)
 Table 17. Global Top Flurbiprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flurbiprofen as of 2024)
 Table 18. Ranking of Global Top Flurbiprofen Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Flurbiprofen Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Flurbiprofen, Headquarters and Area Served
 Table 21. Global Key Players of Flurbiprofen, Product and Application
 Table 22. Global Key Players of Flurbiprofen, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Flurbiprofen Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Flurbiprofen Revenue Market Share by Type (2020-2025)
 Table 26. Global Flurbiprofen Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Flurbiprofen Revenue Market Share by Type (2026-2031)
 Table 28. Global Flurbiprofen Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Flurbiprofen Revenue Market Share by Application (2020-2025)
 Table 30. Global Flurbiprofen Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Flurbiprofen Revenue Market Share by Application (2026-2031)
 Table 32. North America Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Flurbiprofen Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Flurbiprofen Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Flurbiprofen Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Flurbiprofen Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Flurbiprofen Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Flurbiprofen Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Flurbiprofen Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Flurbiprofen Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Flurbiprofen Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Flurbiprofen Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Flurbiprofen Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Teva Company Details
 Table 48. Teva Business Overview
 Table 49. Teva Flurbiprofen Product
 Table 50. Teva Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 51. Teva Recent Development
 Table 52. Mylan Pharmaceuticals Company Details
 Table 53. Mylan Pharmaceuticals Business Overview
 Table 54. Mylan Pharmaceuticals Flurbiprofen Product
 Table 55. Mylan Pharmaceuticals Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 56. Mylan Pharmaceuticals Recent Development
 Table 57. Tokuhon Company Details
 Table 58. Tokuhon Business Overview
 Table 59. Tokuhon Flurbiprofen Product
 Table 60. Tokuhon Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 61. Tokuhon Recent Development
 Table 62. Recordati Company Details
 Table 63. Recordati Business Overview
 Table 64. Recordati Flurbiprofen Product
 Table 65. Recordati Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 66. Recordati Recent Development
 Table 67. Mikasa Seiyaku Company Details
 Table 68. Mikasa Seiyaku Business Overview
 Table 69. Mikasa Seiyaku Flurbiprofen Product
 Table 70. Mikasa Seiyaku Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 71. Mikasa Seiyaku Recent Development
 Table 72. Bausch Health Company Details
 Table 73. Bausch Health Business Overview
 Table 74. Bausch Health Flurbiprofen Product
 Table 75. Bausch Health Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 76. Bausch Health Recent Development
 Table 77. Pfizer Company Details
 Table 78. Pfizer Business Overview
 Table 79. Pfizer Flurbiprofen Product
 Table 80. Pfizer Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 81. Pfizer Recent Development
 Table 82. AbbVie Company Details
 Table 83. AbbVie Business Overview
 Table 84. AbbVie Flurbiprofen Product
 Table 85. AbbVie Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 86. AbbVie Recent Development
 Table 87. Abbott Company Details
 Table 88. Abbott Business Overview
 Table 89. Abbott Flurbiprofen Product
 Table 90. Abbott Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 91. Abbott Recent Development
 Table 92. Allergan Company Details
 Table 93. Allergan Business Overview
 Table 94. Allergan Flurbiprofen Product
 Table 95. Allergan Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 96. Allergan Recent Development
 Table 97. Pharma-Logic Company Details
 Table 98. Pharma-Logic Business Overview
 Table 99. Pharma-Logic Flurbiprofen Product
 Table 100. Pharma-Logic Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 101. Pharma-Logic Recent Development
 Table 102. Kaken Pharma Company Details
 Table 103. Kaken Pharma Business Overview
 Table 104. Kaken Pharma Flurbiprofen Product
 Table 105. Kaken Pharma Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 106. Kaken Pharma Recent Development
 Table 107. Mitsubishi Tanab Company Details
 Table 108. Mitsubishi Tanab Business Overview
 Table 109. Mitsubishi Tanab Flurbiprofen Product
 Table 110. Mitsubishi Tanab Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 111. Mitsubishi Tanab Recent Development
 Table 112. Sun Pharma Company Details
 Table 113. Sun Pharma Business Overview
 Table 114. Sun Pharma Flurbiprofen Product
 Table 115. Sun Pharma Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 116. Sun Pharma Recent Development
 Table 117. Aa Pharma Company Details
 Table 118. Aa Pharma Business Overview
 Table 119. Aa Pharma Flurbiprofen Product
 Table 120. Aa Pharma Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 121. Aa Pharma Recent Development
 Table 122. Pro Doc Limitee Company Details
 Table 123. Pro Doc Limitee Business Overview
 Table 124. Pro Doc Limitee Flurbiprofen Product
 Table 125. Pro Doc Limitee Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 126. Pro Doc Limitee Recent Development
 Table 127. PD-Rx Pharmaceuticals Company Details
 Table 128. PD-Rx Pharmaceuticals Business Overview
 Table 129. PD-Rx Pharmaceuticals Flurbiprofen Product
 Table 130. PD-Rx Pharmaceuticals Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 131. PD-Rx Pharmaceuticals Recent Development
 Table 132. Beijing Taide Pharmaceutical Company Details
 Table 133. Beijing Taide Pharmaceutical Business Overview
 Table 134. Beijing Taide Pharmaceutical Flurbiprofen Product
 Table 135. Beijing Taide Pharmaceutical Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 136. Beijing Taide Pharmaceutical Recent Development
 Table 137. Wuhan Daan Pharmaceutical Company Details
 Table 138. Wuhan Daan Pharmaceutical Business Overview
 Table 139. Wuhan Daan Pharmaceutical Flurbiprofen Product
 Table 140. Wuhan Daan Pharmaceutical Revenue in Flurbiprofen Business (2020-2025) & (US$ Million)
 Table 141. Wuhan Daan Pharmaceutical Recent Development
 Table 142. Research Programs/Design for This Report
 Table 143. Key Data Information from Secondary Sources
 Table 144. Key Data Information from Primary Sources
 Table 145. Authors List of This Report


List of Figures
 Figure 1. Flurbiprofen Picture
 Figure 2. Global Flurbiprofen Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Flurbiprofen Market Share by Type: 2024 VS 2031
 Figure 4. Injection Features
 Figure 5. Patch Features
 Figure 6. Tablet Features
 Figure 7. Global Flurbiprofen Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Flurbiprofen Market Share by Application: 2024 VS 2031
 Figure 9. Nonsteroidal Anti-Inflammatory Drugs Case Studies
 Figure 10. Topical Administration for Joint And Muscle Pain Case Studies
 Figure 11. Soft Tissue Disease Case Studies
 Figure 12. Dysmenorrhea Case Studies
 Figure 13. Post-Operative Pain Case Studies
 Figure 14. Toothache Case Studies
 Figure 15. Other Case Studies
 Figure 16. Flurbiprofen Report Years Considered
 Figure 17. Global Flurbiprofen Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Flurbiprofen Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Flurbiprofen Market Share by Region: 2024 VS 2031
 Figure 20. Global Flurbiprofen Market Share by Players in 2024
 Figure 21. Global Top Flurbiprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flurbiprofen as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Flurbiprofen Revenue in 2024
 Figure 23. North America Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Flurbiprofen Market Share by Country (2020-2031)
 Figure 25. United States Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Flurbiprofen Market Share by Country (2020-2031)
 Figure 29. Germany Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Flurbiprofen Market Share by Region (2020-2031)
 Figure 37. China Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Flurbiprofen Market Share by Country (2020-2031)
 Figure 45. Mexico Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Flurbiprofen Market Share by Country (2020-2031)
 Figure 49. Turkey Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Flurbiprofen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Teva Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 53. Mylan Pharmaceuticals Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 54. Tokuhon Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 55. Recordati Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 56. Mikasa Seiyaku Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 57. Bausch Health Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 58. Pfizer Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 59. AbbVie Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 60. Abbott Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 61. Allergan Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 62. Pharma-Logic Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 63. Kaken Pharma Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 64. Mitsubishi Tanab Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 65. Sun Pharma Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 66. Aa Pharma Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 67. Pro Doc Limitee Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 68. PD-Rx Pharmaceuticals Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 69. Beijing Taide Pharmaceutical Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 70. Wuhan Daan Pharmaceutical Revenue Growth Rate in Flurbiprofen Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart